The record on rosiglitazone and the risk of myocardial infarction.
Psaty
Bruce M
BM
Furberg
Curt D
CD
D002318:Cardiovascular Diseases / Q000139:chemically induced / Q000401:mortality*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D017277:Drug Approval; D004348:Drug Labeling; D006760:Hospitalization; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D015201:Meta-Analysis as Topic; D008875:Middle Aged; D009203:Myocardial Infarction / Q000139:chemically induced*; D011358:Product Surveillance, Postmarketing; D012107:Research Design; D000077154:Rosiglitazone; D045162:Thiazolidinediones / Q000009:adverse effects*; D014481:United States
D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D000077154:Rosiglitazone